期刊文献+

Stat3及其靶基因Cyclin D1在喉鳞状细胞癌组织中的表达及临床意义 被引量:10

Clinical significance of Stat3 and Cyclin D1 expression in laryngeal squamous cell carcinoma
原文传递
导出
摘要 目的:研究喉鳞状细胞癌组织中信号转导和转录激活因子3(Stat3)及其靶基因细胞周期蛋白D1(Cyclin D1)的表达情况并探讨其临床意义。方法:应用Western blot和RT-PCR方法,研究喉鳞状细胞癌组织中Stat3、Cyclin D1蛋白和mRNA的表达情况以及与喉鳞状细胞癌临床病理因素的关系。结果:喉鳞状细胞癌组织中Stat3、Cyclin D1蛋白和mRNA的表达水平明显高于正常喉黏膜组织(P<0.01)。Stat3、Cyclin D1蛋白表达水平与喉鳞状细胞癌临床分期、分化程度及淋巴结转移有关(P<0.01);在喉鳞状细胞癌组织中Stat3蛋白、mRMA与CyclinD蛋白、mRNA的表达均呈正相关(r=0.564、0.552,均P<0.01)。结论:Stat3信号转导通路在喉鳞状细胞癌的发生、发展过程中起重要作用,检测喉鳞状细胞癌组织中Stat3及其靶基因Cyclin D1的表达可以反映肿瘤的恶性程度。 Objective:To examine the expression and clinical significance of the Stat3 and Cyclin D1 in laryngeal squamous cell carcinoma(LSCC).Method:The expression of Stat3 and Cyclin D1 in LSCC tissue were detected by the RT-PCR and Western blot method respectively,and then the relationship between Stat3 and Cyclin D1 protein expression level and relevant clinical factors of LSCC was explored.Result:Compared to the normal larynx mucosa group,the expression level of Stat3 and Cyclin D1 was significantly higher in LSCC(P0.01).The high expression level of Stat3 and Cyclin D1 protein in LSCC was correlated with the clinical stage,tumor differentiation and lymph node metastases(P0.01).The expression level of Stat3 was positively correlated with that of Cyclin D1,The correlation coefficient(r) was 0.564(P0.01) for the protein expression and 0.552(P0.01)for the mRNA expression.Conclusion: Stat3 signaling pathway may play an important role in the tumorigenesis and progression of LSCC.The expression level of Stat3 and its target gene Cyclin D1 can reflect the malignancy degree of LSCC.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2011年第21期966-969,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 鳞状细胞 信号转导和转录激活因子3 细胞周期蛋白D1 carcinoma squamous cell signal transducers and activators of transcription 3 cyclin D1
  • 相关文献

参考文献20

  • 1ALMADORI G, BUSSU F, CADONI G, et al. Mo- lecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach[J]. Eur J Cancer, 2005,41 : 683 - 693.
  • 2DARNELL J E Jr, KERR I M, STARK G R. Jak- Star pathways and transcriptional activation in re- sponse to IFNs and other extracellular signaling pro- teins [J]. Science, 1994,264: 1415- 1421.
  • 3LIBY K, VOONG N, WILLIAMS C R, et al. The synthetic triterpenoid CDDO-imidazolide suppresses STAT phosphorylation and induces apoptosis in mye- loma and lung cancer cells [J]. Clin Cancer Res, 2006,12 : 4288- 4293.
  • 4HUANG S. Regulation of metastases by signal trans- ducer and activator of transcription 3 signaling Path- way: clinical implications[J]. Clin Cancer Res, 2007, 13:1362-1366.
  • 5RAWLINGS J S, ROSLER K M, HARRISON D A. The JAK/STAT signaling pathway[J]. J Cell Sci, 2004,117: 1281- 1283.
  • 6NIU G, WRIGHT K L, HUANG M, et al. Consti- tutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis [J]. Oncogene, 2002, 21: 2000-2008.
  • 7ALVAREZ J V, FEBBO P G, RAMASWAMY S, et al. Identification of genetic signiture of activated STAT3 in human tumors[J]. Cancer Res, 2005, 65: 5054-5062.
  • 8HSIAO J R, JIN Y T, TSAIS T, et al. Constitutive activation of STAT3 and STAT5 is present in the ma- jority of nasopharyngeal carcinoma and correlates with better prognosis[J]. Br J Cancer,2003,89 :344-349.
  • 9SHAH N G, TRIVEDI T I, TANKSHALI R A, et al. Stat3 expression in oral squamous ceil carcinoma: association with clinicopathological parameters and survival [J]. Int J Biol Markers, 2006,21 : 175- 183.
  • 10SHAH N G, TRIVEDI T I, TANKSHALI R A, et al. Stat3 expression in oral squamous cell carcinoma: association with clinicopathological parameters and survival[J]. Int J Biol Markers, 2006,21 : 175- 183.

二级参考文献28

  • 1陈万军,王天铎.鼠抗人单克隆抗体P27^(Kip1)及细胞周期素D1与下咽癌临床关系的研究[J].中华肿瘤杂志,2004,26(6):358-359. 被引量:6
  • 2王俊阁,李晓明,陈英会,路秀英.信号转导和转录激活因子3在喉癌组织中的表达及临床意义[J].临床耳鼻咽喉头颈外科杂志,2007,21(3):113-115. 被引量:17
  • 3ALMADORI G, BUSSU F, CADONI G, et al. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach[J]. Eur J Cancer, 2005,41 : 683 - 693.
  • 4DARNELL J E Jr. , KERR I M, STARK G R. JakSTAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins[J]. Science, 1994,264: 1415-1421.
  • 5IHLE J N. STATs: signal transducers and activators of transcription[J]. Cell, 1996,84 : 331 - 334.
  • 6BOWMAN T, GARCIA R, TURKSON J, et al. STATs in oncogenesis [J]. Oncogene, 2000, 19: 2474-2488.
  • 7BROMBERG J F, WRZESZCZYNSKA M H, DEVGAN G, et al. Stat3 as an oncogen[J]. Cell, 1999, 98: 95-303.
  • 8MASUDA M, SUZUI M, YASUMATU R, et al. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma[J]. Cancer Res,2002,62: 3351-3355.
  • 9SONG J I, GRANDIS J R. STAT signaling in head and neck cancer[J]. Oncogene, 2000, 19: 2489- 2495.
  • 10HSIAO J R, JIN Y T, TSAI S T, et al. Constitutive activation of STAT3 and STATS is present in the majority of nasopharyngeal carcinoma and correlates with Better prognosis[J]. Br J Cancer, 2003, 89: 344-349.

共引文献18

同被引文献136

引证文献10

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部